BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 36914745)

  • 1. Functional precision oncology using patient-derived assays: bridging genotype and phenotype.
    van Renterghem AWJ; van de Haar J; Voest EE
    Nat Rev Clin Oncol; 2023 May; 20(5):305-317. PubMed ID: 36914745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of Genomic Profiling and Organoid Development in Precision Oncology.
    Yoon H; Lee S
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations.
    Letai A; Bhola P; Welm AL
    Cancer Cell; 2022 Jan; 40(1):26-35. PubMed ID: 34951956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical models for precision oncology.
    Ibarrola-Villava M; Cervantes A; Bardelli A
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):239-246. PubMed ID: 29959990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalization of the medical treatment of solid tumours using patient-derived tumour explants (Review).
    Louandre C; Donnadieu J; Lachaier E; Page C; Chauffert B; Galmiche A
    Int J Oncol; 2016 Mar; 48(3):895-9. PubMed ID: 26783093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing Modern Diagnostic Pathology for Patient-Derived Soft Tissue Sarcosphere Models in the Era of Functional Precision Oncology.
    Chen Y; Herzog M; Pliego-Mendieta A; Bühler MM; Harnisch KJ; Haberecker M; Arnold F; Planas-Paz L; Pauli C
    Lab Invest; 2023 Apr; 103(4):100039. PubMed ID: 36870294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Future of Precision Oncology.
    Rulten SL; Grose RP; Gatz SA; Jones JL; Cameron AJM
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards personalized computational oncology: from spatial models of tumour spheroids, to organoids, to tissues.
    Karolak A; Markov DA; McCawley LJ; Rejniak KA
    J R Soc Interface; 2018 Jan; 15(138):. PubMed ID: 29367239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of precision oncology-guided treatment paradigms.
    DasGupta R; Yap A; Yaqing EY; Chia S
    WIREs Mech Dis; 2023 Jan; 15(1):e1585. PubMed ID: 36168283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiogenomics: a key component of precision cancer medicine.
    Liu Z; Duan T; Zhang Y; Weng S; Xu H; Ren Y; Zhang Z; Han X
    Br J Cancer; 2023 Sep; 129(5):741-753. PubMed ID: 37414827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
    Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
    Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future.
    Akhoundova D; Rubin MA
    Cancer Cell; 2022 Sep; 40(9):920-938. PubMed ID: 36055231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision oncology using ex vivo technology: a step towards individualised cancer care?
    Williams ST; Wells G; Conroy S; Gagg H; Allen R; Rominiyi O; Helleday T; Hullock K; Pennington CEW; Rantala J; Collis SJ; Danson SJ
    Expert Rev Mol Med; 2022 Oct; 24():e39. PubMed ID: 36184897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
    Gerhards NM; Rottenberg S
    Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?
    Panovska D; De Smet F
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed.
    Pfohl U; Pflaume A; Regenbrecht M; Finkler S; Graf Adelmann Q; Reinhard C; Regenbrecht CRA; Wedeken L
    Cells; 2021 Apr; 10(4):. PubMed ID: 33920536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Medicine in Oncology Pharmacy Practice.
    Saadeh C; Bright D; Rustem D
    Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational oncology--mathematical modelling of drug regimens for precision medicine.
    Barbolosi D; Ciccolini J; Lacarelle B; Barlési F; André N
    Nat Rev Clin Oncol; 2016 Apr; 13(4):242-54. PubMed ID: 26598946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.